AzTrials
AzTrials

ExanimationNCT07386782

Palpatory and Ultrasonographic Assessment of Tissue Compressibility: Validation and Learning Effects in Phantom Models

An observational study of Exanimation and Diagnostic Ultrasound, run by Insel Gruppe AG, University Hospital Bern at 1 site in Switzerland.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This validation study compares clinical palpation and ultrasonographic measurements of tissue compressibility using standardized phantom models. Operators with different levels of clinical and ultrasound experience perform repeated, blinded assessments across multiple sessions. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Exanimation, Diagnostic Ultrasound, Palpation
What is being tested?
Ultrasonographic Compression Measurment and Palpation of Standardized Phantom Models
How many people
40 participants
Where
1 siteSwitzerland
Study dates
31 Jan 2026to 31 May 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Participants with different years of clinical experience and levels of experience in ultrasound diagnostics (medical students, residents, and attendings) will be included. Age >= 18 years.

Who may be able to join

  • Medical professionals and medical students

Who cannot join

  • Age <18 years

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Inselspital Bern

    Bern, 3010

Other trials in Switzerland

About this study

This validation study compares clinical palpation and ultrasonographic measurements of tissue compressibility using standardized phantom models. Operators with different levels of clinical and ultrasound experience perform repeated, blinded assessments across multiple sessions. The study evaluates accuracy, reliability, agreement between modalities, and learning effects over time, aiming to support standardized and more objective assessment of tissue compressibility in clinical practice.

Being tested
Ultrasonographic Compression Measurment and Palpation of Standardized Phantom Models
Keywords
Exanimation, Diagnostic Ultrasound, Palpation
Medical subject headings
Coma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasonographic Compression Measurment and Palpation of Standardized Phantom ModelsBehavioural

    Repeated ultrasonographic compression measurements and palpation of standardized phantom models

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Accuracy and reliability of palpation and ultrasonographic compression measurements

    Intraoperator and interoperator accuracy and reliability of palpation and ultrasonographic compression measurements on two phantom models as intraclass correlation coefficient and linear mixed-effects model

    Measured: Over 3 sessions, seperated by at least 1 day and at most 1 week (study duration: 3 days to 2 weeks)

Secondary outcomes (3)
  1. Effect of operator characteristics on the measurement accuracy and reliability.

    Operator characteristics (age, gender, level of experience) will be introduced as fixed effects in a linear mixed-effects model with a random effect for participants to account for repeated measurements

    Measured: Over 3 sessions, seperated by at least 1 day and at most 1 week (study duration: 3 days to 2 weeks)

  2. Assess the learning curve in palpation and ultrasound measurements

    Changes in accuracy of both modalities using linear mixed-effects model with a random effect for participants to account for repeated measurements. To test possible confounding factors, they will be introduced as fixed effects.

    Measured: Over 3 sessions, seperated by at least 1 day and at most 1 week (study duration: 3 days to 2 weeks)

  3. Correlate the compression measurements with palpatory assessment

    Correlation of both modalities using linear mixed-effects model with a random effect for participants to account for repeated measurements. To test possible confounding factors, they will be introduced as fixed effects.

    Measured: Over 3 sessions, seperated by at least 1 day and at most 1 week (study duration: 3 days to 2 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Feb 2026
  2. Study start31 Jan 2026
  3. Primary completion30 Apr 2026 (estimated)
  4. Study completion31 May 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07386782
Sponsor's protocol ID
Req-2025-01655
Status last verified
Apr 2026
First submitted
20 Jan 2026
Last updated
17 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data supporting this study's findings are available upon request from Samuel Tschopp, the corresponding author.

Questions about this trial

What is this clinical trial studying?

An observational study of Exanimation and Diagnostic Ultrasound, run by Insel Gruppe AG, University Hospital Bern at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 17 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Accuracy and reliability of palpation and ultrasonographic compression measurements (time frame: Over 3 sessions, seperated by at least 1 day and at most 1 week (study duration: 3 days to 2 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in